Skip to main content

Table 1 Definitions of indicators in TablesĀ 3 and 4

From: Evaluation and pilot implementation of essential interventions for the management of hypertension and prevention of cardiovascular diseases in primary health care in the Republic of Tajikistan

Risk factors

Current smoker

Proportions of smokers. Patients were assumed to be non-smokers if smoking status was not specified.

Diabetes

Proportion of patients with a medical diagnosisa of diabetes mellitus. Patients were assumed to be non-diabetic if diabetes status was not specified.

History of CVD

Proportion of patients with a medical diagnosisb of cardiovascular disease

SBP/DBP

Mean based on the most recent systolic/diastolic blood pressure measurementc

Process indicators

Smoking status recorded

Proportion of patients with smoking status recorded

BP measured regularly

Proportion of patients with two documented BP measurementsc

Fasting glucose tested

Proportions of patients with fasting glucose tested

Total cholesterol tested

Proportions of patients with total cholesterol tested

WHO/ISH risk score documented

Proportions of patients aged 40 years or more with a WHO/ISH CVD risk score documented by health workers based on age, sex, BP, smoking status, diabtes status, and total blood cholesterol

WHO/ISH risk score calculatable

Proportions of patients aged 40 years or more with all risk factors (age, sex, BP, smoking status, diabetes status, and total blood cholesterol) recorded to calculated the WHO/ISH CVD risk score. Patients were assumed to be non-smoker if smoking status was not specified and to be non-diabetic if diabetes status was not specified. Predictions charts without total cholesterol were applied for those without measurement. The most recent BP and total cholesterol had to be during the last 24 months.

High-risk patients

Proportions of patients with a calculatedd WHO/ISHā€‰ā‰„ā€‰30ā€‰% or/and a history of CVD

BP lowering drug prescribed

Proportions of patients with BP lowering drug prescribed

Statin prescribed for high-risk patients

Proportions of high-risk patients (calculatedd WHO/ISHā€‰ā‰„ā€‰30ā€‰% or/and history of CVD

Aspirin prescribed for high-risk patients

Proportions of high-risk patients (calculatedd WHO/ISHā€‰ā‰„ā€‰30ā€‰% or/and history of CVD) prescribed aspirin

Triple therapy prescribed for high-risk patients

Proportions of high-risk patients (calculatedd WHO/ISHā€‰ā‰„ā€‰30ā€‰% or/and history of CVD) prescribed triple therapy (statin, aspirin, and blood pressure medication)

Outcome indicator

BP at normal range

Proportion of patients whose most recent BP measurementc was at normal range (SBPā€‰<ā€‰140 mmHg and DBPā€‰<ā€‰90 mmHg)

High-risk patients with BP at normal range

Proportion of high-risk patients (calculatedd WHO/ISHā€‰ā‰„ā€‰30ā€‰% or/and history of CVD) whose most recent BP measurementc was at normal range (SBPā€‰<ā€‰140 mmHg and DBPā€‰<ā€‰90 mmHg)

Low-risk patients with BP at normal range

Proportion of low-risk patients (calculatedd WHO/ISHā€‰<ā€‰30ā€‰% and no history of CVD) whose most recent BP measurementc was at normal range (SBPā€‰<ā€‰140 mmHg and DBPā€‰<ā€‰90 mmHg)

  1. CVD cardiovascular disease; SBPĀ systolic blood pressure; DBPĀ diastolic blood pressure; BPĀ blood pressure; WHO/ISH risk score, World Health Organization/International Society of Hypertension cardiovascular risk score.
  2. a Diagnoses written either using ICD-10 codes or as names of diseases to the section of permanent diagnoses in the patient records are taken into account.
  3. b Diagnoses written either using ICD-10 codes or as names of diseases or events in the patient records are taken into account.
  4. c Measured during the last 12 months.
  5. d Calculated by the authors of this study.